Nebius Group's stock fell 23.58% in September after a strong rally that lifted it 153.5% year to date, driven by explosive revenue growth of 454% in Q2 2026. Despite the recent pullback, Arete Research raised its price target to $415, implying a 96% upside, based on Nebius' $40 billion contracted backlog and multi-year deals with major hyperscalers like Microsoft and Meta. The company maintains strong adjusted EBITDA margins and expects significant revenue growth in 2026. The main risks include high capital expenditure, customer concentration, and potential dilution from convertible debt, but the fundamentals support a cautiously optimistic outlook.
Nebius Group NV holds a market cap of $57.68 billion and an enterprise value of $59.81 billion as of September 15, 2026, 18:13 WIB. On Pluang, NBIS shares trade at $214.22, showing a modest 0.96% gain on the day. This trading activity occurs after a significant pullback in September, highlighting ongoing investor interest despite recent volatility.
Shares of CoreWeave, Nebius, and Oracle fell significantly due to concerns about their heavy borrowing to finance AI infrastructure expansion. CoreWeave led the decline with a 7% drop, followed by Nebius down 6% and Oracle down 5%, while broader clou...
Nebius has rapidly converted a $37.49 billion AI compute contract backlog into revenue, driving a 183% gain this year. Key deals with Meta and Microsoft fuel growth, with Q2 revenue up 454% to $582.3 million and strong EBITDA margins. However, the co...
